ESR1 and breast cancer: In detail, those highly invasive BC cell lines, such as MDA-MB-231 and BT-549 presented lower expression levels of ARSD, whereas the ER positive MCF-7 and T47D cell lines presented higher expression levels of ARSD (Fig. 2C–E and Supplement Fig. 2B).